Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile

Rifaximin is a rifampicin derivative, poorly absorbed by the gastro-intestinal tract. We studied the in vitro susceptibility to rifamixin of 1082 Clostridium difficile isolates; among these,184 isolates from a strain collection were tested by an in-house rifaximin disc (40 µg) diffusion test, by an...

Descripción completa

Detalles Bibliográficos
Autores principales: Huhulescu, Steliana, Sagel, Ulrich, Fiedler, Anita, Pecavar, Verena, Blaschitz, Marion, Wewalka, Guenther, Allerberger, Franz, Indra, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for General Microbiology 2011
Materias:
Clostridium Difficile
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167878/
https://www.ncbi.nlm.nih.gov/pubmed/21292853
http://dx.doi.org/10.1099/jmm.0.028571-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167878/
https://www.ncbi.nlm.nih.gov/pubmed/21292853
http://dx.doi.org/10.1099/jmm.0.028571-0

Ejemplares similares